1-4 of 4
Matthias Niedermeier
Close
Sort by
Journal Articles

Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell–mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach

Matthias Niedermeier, Bryan T. Hennessy, Zachary A. Knight, Marina Henneberg, Jianhua Hu, Antonina V. Kurtova, William G. Wierda, Michael J. Keating, Kevan M. Shokat, Jan A. Burger
Journal: Blood
Blood (2009) 113 (22): 5549–5557.
https://doi.org/10.1182/blood-2008-06-165068
Published: 2009
Includes: Supplemental data
Journal Articles

High-Level Expression of the T Cell Chemokines CCL3 and CCL4 by Chronic Lymphocytic Leukemia B Cells in Nurselike Cell Co-Cultures and in Response to BCR Stimulation.

Jan A. Burger, MD, PhD, Matthias Niedermeier, PhD, Andrea Bürkle, MD, Elena Hartmann, MD, William G. Wierda, MD, PhD, Michael J. Keating, MD, Andreas Rosenwald, MD
Journal: Blood
Blood (2007) 110 (11): 342.
https://doi.org/10.1182/blood.V110.11.342.342
Published: 2007
Journal Articles

CD62L (L-Selectin), CXCR4, CD49d, and CD38 Contribute to Migration of Chronic Lymphocytic B Cells Beneath Marrow Stromal Cells.

Maite Quiroga, BS, Marina Henneberg, BS, Matthias Niedermeier, PhD, Jan A. Burger, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1119.
https://doi.org/10.1182/blood.V110.11.1119.1119
Published: 2007
Journal Articles

Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia

Andrea Bürkle, Matthias Niedermeier, Annette Schmitt-Gräff, William G. Wierda, Michael J. Keating, Jan A. Burger
Journal: Blood
Blood (2007) 110 (9): 3316–3325.
https://doi.org/10.1182/blood-2007-05-089409
Published: 2007